|
Volume 272, Number 34,
Issue of August 22, 1997
pp. 20967-20970
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
COMMUNICATION:
Cyclic ADP-ribose Enhances Coupling between Voltage-gated
Ca2+ Entry and Intracellular Ca2+ Release*
(Received for publication, May 22, 1997, and in revised form, June 11, 1997)
Ruth M.
Empson
and
Antony
Galione
From the Department of Pharmacology, University of Oxford,
Mansfield Road, Oxford OX1 3QT, United Kingdom
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
Ca2+ release from intracellular
stores can be activated in neurons by influx of Ca2+
through voltage-gated Ca2+ channels. This process, called
Ca2+-induced Ca2+ release, relies on the
properties of the ryanodine receptor and represents a mechanism by
which Ca2+ influx during neuronal activity can be amplified
into large intracellular Ca2+ signals. In a differentiated
neuroblastoma cell line, we show that caffeine, a pharmacological
activator of the ryanodine receptor, released Ca2+ from
intracellular stores in a Ca2+-dependent and
ryanodine-sensitive manner. The pyridine nucleotide, cyclic ADP-ribose,
thought to be an endogenous modulator of ryanodine receptors also
amplified Ca2+-induced Ca2+ release in these
neurons. Cyclic ADP-ribose enhanced the total cytoplasmic
Ca2+ levels during controlled Ca2+ influx
through voltage gated channels, in a concentration-dependent and
ryanodine-sensitive manner and also increased the sensitivity with
which a small amount of Ca2+ influx could trigger
additional release from the ryanodine-sensitive intracellular
Ca2+ stores. Single cell imaging showed that following the
Ca2+ influx, cyclic ADP-ribose enhanced the spatial spread
of the Ca2+ signal from the edge of the cell into its
center. These powerful actions suggest a role for cyclic ADP-ribose in
the functional coupling of neuronal depolarization, Ca2+
entry, and global intracellular Ca2+ signaling.
INTRODUCTION
Calcium-induced calcium release (or
CICR),1 is a means of
amplifying intracellular cytosolic Ca2+ signals.
Ca2+ entering a cell, for example through voltage-sensitive
channels, can trigger the release of further Ca2+ from the
intracellular stores (1-3). The mechanism relies upon the distinct
properties of the ryanodine receptor, in particular its ability to
control Ca2+ release from the store and the sensitivity of
its gating mechanism to Ca2+ (4, 5). A wide variety of
neurons, both cultured and acutely isolated, possess
ryanodine-sensitive intracellular Ca2+ stores (6-9) and
also express ryanodine receptors (9-12). A number of recent studies
have emphasized the importance of Ca2+ release from
intracellular stores during physiological neuronal activity (13),
during changes in synaptic efficacy that may be involved in learning
processes (14-16), as part of the mechanism of neurotransmitter
release (17), and even during neuronal development (18). Caffeine (4)
and cyclic ADP-ribose, the novel Ca2+-mobilizing pyridine
nucleotide originally discovered in the sea urchin egg (19), both
release Ca2+ from intracellular stores via modulation of
the ryanodine receptor (20, 21). In the last few years cyclic
ADP-ribose has begun to emerge as a potential physiological regulator
of ryanodine-sensitive Ca2+-dependent processes
in a number of intact mammalian systems. Cyclic ADP-ribose modulates
excitation-contraction coupling in the heart (22), it alters
excitability of pancreatic acinar cells (23) and dorsal root ganglion
cells (24), and stimulates Ca2+ release from the
intracellular stores of T-lymphocytes (25). Using a combination of
electrophysiology and Ca2+ imaging we show here, in intact
mammalian cultured neuroblastoma cells (26), that release from
ryanodine-sensitive intracellular stores is coupled to Ca2+
influx via voltage-activated channels and potentiated by cyclic ADP-ribose applied through the recording electrode.
EXPERIMENTAL PROCEDURES
NG108-15 neurons, a mouse neuroblastoma × rat glioma
hybrid culture (obtained from the European Collection of Cell Cultures, Porton, UK), were cultured as described previously (26, 27).
For Ca2+ measurements in intact cells, the cells were
loaded with Fura-2 using the acetoxymethyl ester loading technique for a maximum loading period of 15 min. Before commencing experiments the
cells were washed three times in the perfusion buffer containing 130 mM NaCl, 10 mM HEPES, 5 mM KCl, 5 mM CaCl2, 1 mM MgCl2,
25 mM glucose, on the stage of the upright microscope
(Zeiss, Oberkochen, Germany). To depolarize the cells, 30 mM KCl (and an equimolar reduction in Na+ ions)
was switched into the perfusion flow (rate varied between 1 and 1.5 ml/min). Changes in Ca2+ were measured every 4 s in
these experiments using ratiometric determinations of image intensity
following excitation with 340- and 380-nm wavelength light supplied by
a TILL Photonics monochromator (Planegg, Germany) controlled by
Improvision (Leicester, UK) "Ionvision" software (as described
previously (28)). An in vitro calibration using the
Ionvision software was used to analyze average Ca2+
changes, over the whole cell, in individual cells from the pseudocolor images, as described previously. The same experimental set up and
analysis was used to determine Ca2+ changes during the
electrophysiological experiments, except that an image was captured
every 0.8-1.2 s. Variations in intracellular Ca2+ in
different regions of the cell were also measured with the same
calibrations and software using small rectangular regions of interest.
Electrophysiological recordings were made in the whole cell patch clamp
mode using an Axopatch 200A (Axon Instruments, Foster City, CA) with
pipettes of resistance 2-6 M . Seal resistances prior to
breakthrough were always greater than 1 G . Cells settled and filled
with Fura-K+ for approximately 10 min after breakthrough.
Current and voltage signals were digitized using an ITC-16 A/D
converter (Instrutech Corp., Great Neck, NY) and the experiments
controlled using the Axodata program (Axon Instruments) through the
same interface. The intracellular solution contained 135 mM
CsCl, 10 mM HEPES, 1 mM Mg-ATP, 100 µM Fura-2-pentapotassium salt, and extracellular solution
contained 130 mM NaCl, 10 mM HEPES, 5 mM KCl, 5 mM tetraethylammonium chloride, 5 mM CaCl2, 5 mM 4-aminopyridine, 1 mM MgCl2, 25 mM glucose, and 1 µM tetrodotoxin. Both intra- and extracellular solutions
were designed to block K+ and Na+ channels, so
that during cellular depolarization the area beneath the inward
current, measured with Axograph (Axon Instruments), an indication of
the charge entering the cell, represented the entry of Ca2+
and not other cations. Ca2+ (or charge) entry was
controlled by changing the duration of the +60- or +80-mV voltage step
evoked from a holding potential of 70 or 90 mV. Voltage steps were
applied in a random order, every 20-30 s to avoid excessive run-down
of the Ca2+ current with linear on-line leak subtraction.
For each voltage step the peak Ca2+ change was measured and
divided by the area beneath the current trace (pA × s or pC) to
express the unit Ca2+ transient (29), Ca2+/pC
(pA × s) charge entering the cell. Three voltage steps were used to
calculate a mean value of the unit Ca2+ transient at each
step duration. All experiments were conducted at room temperature. All
values are compared with a Student's t test, and values are
means ± standard error of the mean. All materials were obtained
from Sigma (Poole, UK) except Fura-2, which was from Molecular
Probes.
RESULTS AND DISCUSSION
Initial studies showed that these differentiated neuroblastoma
cells responded to high concentrations of caffeine, 20-50
mM, with small increases in intracellular Ca2+
(Fig. 1A). The responses
persisted in the absence of extracellular Ca2+, indicating
that these cells possess an intracellular, caffeine-sensitive Ca2+ store. If the NG108-15 cells were first depolarized
with 30 mM K+, we observed a rise in
intracellular Ca2+ as observed previously (30), consistent
with influx of Ca2+ through N and L-type voltage-sensitive
Ca2+ channels present on the plasma membrane (open
bar, Fig. 1B). Application of caffeine, immediately
after the depolarization, then gave a fast and large intracellular
Ca2+ rise (Fig. 1, B and C). The
responses resembled those seen in bullfrog and rat sympathetic neurons
and also in rodent central neurons (6, 7, 31). The caffeine responses
were blocked by ryanodine (5-10 µM), an antagonist of
the ryanodine receptor at these concentrations (see legend to Fig. 1).
This result shows that Ca2+ entry by prior depolarization
sensitized the ryanodine receptors on the intracellular stores to
subsequent activation by caffeine and represented a form of CICR. A
concentration response curve (Fig. 1D) shows a steep
response to caffeine in the presence of the prior depolarization,
strongly indicating the operation of an amplification process.
Fig. 1.
A, intracellular Ca2+ levels
were increased by 50 mM caffeine, indicated by the
filled bar. B, depolarization of the cells with 30 mM external K+, as shown by the open
bar, lead to an increase in Ca2+ levels through the
opening of N and L-type voltage-sensitive Ca2+ channels
(30). Subsequent application of 50 mM caffeine
(filled bar) leads to a marked increase in Ca2+
levels, as shown for all cells in C. In the absence of
extracellular Ca2+, as shown by the dotted line,
depolarizations did not lead to significant rises in intracellular
Ca2+, nor did it enhance caffeine-induced Ca2+
release, rather Ca2+ changes were not significantly
different to the results when caffeine was applied alone, 172 ± 20 nM Ca2+ (n = 5)
p = 0.24, t test. These responses were
reduced by extracellular application of 10 µM ryanodine,
mean caffeine-induced Ca2+ rises were 658 ± 113 reduced to 91 ± 25 nM Ca2+
(n = 8, p = 0.004, paired t
test). D, concentration response curve showing the sharp
increase in the predepolarization caffeine-induced intracellular
Ca2+ rises in response to raised caffeine concentrations,
values are means ± S.E. of the mean for at least three separate
experiments and between five and nine cells.
[View Larger Version of this Image (23K GIF file)]
Having established that these neurons possessed a
ryanodine-sensitive CICR capability, we next sought to estabish
whether cADPR, a positive modulator of the ryanodine receptor, could
potentiate CICR in these cells. Since cADPR is not membrane-permeable,
we applied it to the cells via a whole cell patch pipette and
simultaneously used voltage clamp to control the membrane potential of
the cell. This allowed us to control Ca2+ influx through
voltage-sensitive Ca2+ channels. Previous studies have
successfully used a method called the unit Ca2+ transient
to relate the change in intracellular Ca2+ levels directly
to the amount of charge entering the cell (29, 32, 33). The amount of
charge entering the cell was estimated from the area beneath the
current trace that represented Ca2+ entry, since
K+ and Na+ channels were blocked. By dividing
the peak Ca2+ rise simultaneously recorded during the
voltage step, by the area beneath the current trace, we calculated a
unit Ca2+ transient expressed as nanomolar Ca2+
release per picocoulomb of charge entry. As shown in Fig.
2A, increasing the length of
the voltage step from 100 to 1000 ms allowed the Ca2+
channels to stay open for longer, thus allowing more Ca2+
to enter the neuron. The cell in Fig. 2 was recorded using a pipette
containing 10 µM cADPR, and it can be seen that relative to a rather modest increase in the area beneath the Ca2+
current traces, the longer voltage steps evoked a large increase in the
intracellular, simultaneously measured Ca2+ level (Fig.
2B). This was consistent with extra Ca2+ being
released from the intracellular stores triggered by the initial
Ca2+ entry and had the effect of increasing the absolute
value of the unit Ca2+ transient, above that seen in a
control cell (Fig. 2C). Note also that the red
Ca2+ trace (Fig. 2B) showed an
additional later Ca2+ release following the initial peak, a
common occurrence in cells treated with cADPR. The effects of cADPR
present in the patch pipette are illustrated by the images of two cells
with similar charge entry during a depolarizing pulse (Fig.
2D). Particularly notable is the larger Ca2+
rise in the cADPR-treated cell compared with control. Also apparent, after application of the depolarizing pulse, was the rise in
Ca2+ at the edge of the cell before Ca2+ rose
in the center of the cell, and a striking difference was the relatively
larger elevation in Ca2+ at the center of the cADPR-treated
cells compared with control. By placing two small regions of interest
over the edge and center of the cells and using the Ca2+
rises in these regions to calculate a unit Ca2+ transient,
we observed a 120% increase in the unit Ca2+ transient in
the center of cADPR-treated cells compared with the center of control
cells (n = 9). This suggested that cADPR increased the
likelihood with which elevated Ca2+ levels close to the
plasma membrane propagated to the center of the cell to give a global
Ca2+ signal over the whole of the cell (34).
Fig. 2.
A, whole cell voltage clamp
electrophysiological recording of a cell showing the characteristic
inward Ca2+ current traces evoked upon depolarization of
the membrane by 60 mV from a holding potential of 70 mV. Note the
initial larger amplitude transient current, O, and the smaller
sustained inward current, 255. Both components were reduced by the
L-type Ca2+ channel antagonist diltiazam (10 µM) by 44 ± 7% and 68 ± 9%, respectively
(n = 6). This confirms previous studies, which also suggest that the initial fast inactivating current is a result of the
activation of an N-type channel (41, 42), while the later component
results from the opening of an L-type Ca2+ channel (42).
B, below the current records are the simultaneously measured
Ca2+ levels inside the cell. The colors of the
Ca2+ traces correspond to the colors of the current traces.
The arrow shows the time the voltage step was applied, and
note the different time scales of the Ca2+ changes and the
current responses. The pipette used to record this cell contained 10 µM cADPR that potentiated the measured Ca2+
rises when longer voltage steps, leading to prolonged inward currents
(red, green, and yellow) triggered an enhanced
Ca2+ release. By measuring the area beneath the current
trace, pA multiplied by seconds, we obtained a direct indication of the charge, pC, entering the cell. Since all channels except
voltage-sensitive Ca2+ channels were pharmacologically
blocked, this charge entry represented Ca2+ entry. This
charge was then expressed as a function of the Ca2+ rise
measured inside the cell, to give the unit Ca2+ transient.
In C, the unit transient calculated for this cell at each
duration voltage step (from three separate voltage step applications)
is plotted against the duration of the step. Also shown, in
black, are values from a representative control cell. D, pseudocolor images of a control cell and a cell treated
with 10 µM cADPR. Images are sequential left
to right and taken at 1.4-s intervals, the white
arrow represents the time at which the voltage step was applied.
The charge entry was similar in both cells. The pseudocolor images show
that the edges of the cells were always the first regions to increase,
presumably as Ca2+ entered the cell following the
depolarization. In the cADPR-treated cell there was a significant rise
of Ca2+ in the center of the cell after the influx, whereas
in the control cell the rise in Ca2+ in the center was less
apparent and more confined to the edges. Calibration of the pseudocolor
is shown and ranges from 0 to 1400 nM Ca2+,
blue to red. The pipette is attached to the cell
at the top right-hand corner of each cell. Mean whole cell
resistance was 783 ± 70.3 M (n = 38), and
there was no significant difference in the whole cell input resistance
between control cells and cells treated with cADPR (p = 0.5, t test) or in the areas beneath the evoked
Ca2+ currents, in cADPR-treated cells compared with
controls (p = 0.34, t test).
[View Larger Version of this Image (50K GIF file)]
When Ca2+ levels over the whole cell were measured and
compared for all cells, as the duration of the voltage step was
increased, the increase in the unit transient was greatest in the cells
treated with cADPR (Fig. 3A).
Controls also demonstrated a rise in the unit transient (33) as more
Ca2+ entered the cell, and it is tempting to suggest that
this was due to low levels of endogenous cADPR found in a number of
brain preparations (35). In response to the short 100-ms duration voltage step, the unit Ca2+ transient was approximately 1.4 when charge (or Ca2+) entry was 25.4 ± 3.6 pC, rising
to a value of around 2.5 (see Fig. 3A), indicating
additional release of Ca2+ from the internal stores, as the
amount of charge (or Ca2+) entry was increased to
101.6 ± 14.5 pC as the length of the voltage step increased to
1000 ms. Addition of 10 µM cADPR to the patch pipette
increased the unit Ca2+ transient in two ways. First it
increased the value of the unit Ca2+ transient, compared
with control, even following a short, 100-ms duration voltage step
(Fig. 3, filled circles compared with open squares,
p = 0.007, t test). A direct comparison shows that
for a similar charge (or Ca2+) entry to the controls,
30.7 ± 11.6 pC (p = 0.24, t test),
during the shortest 100-ms duration voltage step, the presence of cADPR in the pipette gave rise to a unit Ca2+ transient of
approximately 2.8, consistent with release of Ca2+ from
intracellular stores. Since a similar charge entry in controls failed
to elicit Ca2+ release from the intracellular stores, but
100 pC could, our result indicates that cADPR reduced, by approximately
3-fold, the amount of Ca2+ entry required to trigger
additional Ca2+ release from the internal stores. Second,
as the length of the voltage step was increased and more
Ca2+ entered the cell, the presence of cADPR resulted in a
relatively larger increase in the unit Ca2+ transient,
compared with the controls (even though the absolute values of charge
entry were similar between control and cADPR-treated cells,
p = 0.34, t test). This suggested that cADPR
allowed the extra Ca2+ entry evoked by depolarizations
longer than 100 ms, to trigger even further release of Ca2+
from the intracellular stores. We noted that the values of the unit
transient were similar to those observed in isolated dorsal root
ganglion cells (33, 36), but approximately 10 × larger than those
observed in bullfrog neurons (29). This difference could relate to the
much larger amplitude of the Ca2+ currents in the bullfrog
neurons and may reflect a greater degree of Ca2+ buffering
of the larger Ca2+ entry compared with the smaller currents
evoked in these mammalian neurons.
Fig. 3.
A, mean changes in the unit
Ca2+ transients with increasing length of the voltage step,
in control cells ( ) compared with those recorded with pipettes
containing 10 µM cADPR ( ). The absolute values of the
mean unit Ca2+ transient in the cADPR-treated cells were
significantly increased at all pulse lengths compared with control
(p < 0.05, t test, all duration pulses,
n = 5), and a large increase was seen as the pulse
length increased. In the control cells the longer pulse lengths also
evoked an increase in the unit Ca2+ transient consistent
with an extra release of Ca2+ from the intracellular stores
(n = 7 cells, p < 0.05, t
test, comparing 100 ms pulse duration with 1000-ms pulse duration). Note also that the unit Ca2+ transient evoked by a 100-ms
duration pulse in the cADPR-treated cells was significantly increased
compared with the control, p < 0.05, t
test. There were no differences in the basal Ca2+ levels
observed in control cells compared with those treated with 10 µM cADPR, mean values were 278 ± 24 nM
for controls and 277 ± 25 nM for cADPR-treated cells,
p = 0.48, t test. 10 µM
ryanodine reduced the change in the unit Ca2+ transients in
both control and cADPR-treated cells (n = 3 for both,
there being no significant difference in the effects of ryanodine in
the two conditions, p = 0.33, t test). Unit
Ca2+ transients at 1000 ms were also effectively reduced by
the inclusion of 20 µM ruthenium red into the pipette and
also in separate experiments by 10 mM Mg2+
(43), mean values were 1.5 ± 0.5 and 0.8 ± 0.8, n = 4 and 3, respectively. B, concentration
response curve for the actions of cADPR, showing the increase in the
value of the unit Ca2+ transient calculated during a
1000-ms voltage step, with different concentrations of intracellularly
applied exogenous cADPR. Values are taken from between 5 and 8 cells at
each concentration and represent a larger data set than shown in Fig.
3A.
[View Larger Version of this Image (18K GIF file)]
Inositol trisphosphate also enhances release of Ca2+ from
intracellular stores in a Ca2+-dependent
manner, so called inositol trisphosphate-induced Ca2+
release (IICR) (2, 34). However we did not observe any effect on the
unit Ca2+ transient when 50 µM
InsP3 was included in the patch pipette, even though a
number of studies suggest that these neuroblastoma cells express
InsP3-sensitive intracellular Ca2+ stores
(37-39) (mean value in the presence of InsP3 following a
1-s pulse was 2.6 ± 1.0 compared with 2.8 ± 0.7 for
control, p = 0.4, t test).
10 µM ryanodine, an inhibitor of CICR, decreased the unit
Ca2+ transient during the shorter, 100-ms voltage step and
also blocked the increase in the unit Ca2+ transient with
increasing pulse duration in both control cells and in cells treated
with 10 µM cADPR (Fig. 3, open triangles) A
similar blockade occurred when either 10 mM
Mg2+ or 20 µM ruthenium red were included in
the pipette solution (see legend to Fig. 3A). All these
treatments indicate that exogenously applied cADPR, acting on or close
to the ryanodine receptor, increased the sensitivity of CICR in these
neurons. cADPR did this in two ways: first, it reduced the amount of
Ca2+ entry required to trigger additional Ca2+
release from the internal stores and second, by increasing the value of
the unit Ca2+ transient, it increased the total amount of
Ca2+ released from intracellular stores for a given
controlled Ca2+ influx. This increase in the unit
Ca2+ transient occurred in a
concentration-dependent manner (Fig. 3B). 50 and
100 µM cADPR increased the unit Ca2+
transient to a level 3-fold over control, indicating that cADPR action
reached a maximum.
Our results show that this neuronal cell line possessed ryanodine- and
caffeine-sensitive intracellular Ca2+ stores. Cyclic
ADP-ribose, in the presence of Ca2+ influx, increased the
amount of Ca2+ released from the intracellular store in
these cells and also increased the sensitivity with which
Ca2+ entry triggered additional Ca2+ release
leading to a global intracellular Ca2+ rise. These actions
of cADPR suggest a requirement for powerful regulatory mechanisms to
control the production of cytosolic levels of cADPR from its ubiquitous
precursor, -NAD+ (40). As Ca2+ release from
internal stores becomes more widely recognized as part of neuronal
Ca2+ homeostasis, an increased understanding of the factors
controlling endogenous levels of cADPR in neurons is now required.
FOOTNOTES
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 44-1865-271890;
Fax: 44-1865-271853; E-mail: ruth.empson{at}pharm.ox.ac.uk.
1
The abbreviations used are: CICR,
Ca2+-induced calcium release; cADPR, cyclic ADP-ribose;
InsP3, inositol trisphosphate; pA, picoamps; pC,
picocoulomb(s).
ACKNOWLEDGEMENTS
We acknowledge the support of the
Wellcome Trust and also thank Dr. A. A. Genazzani for helpful
discussions.
REFERENCES
-
Verkhratsky, A., and Shmigol, A.
(1996)
Cell Calcium
19,
1-14
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kostyuk, P. G., and Verkhratsky, A. N.
(1995)
Calcium Signalling in the Nervous System, pp. 39-57, John Wiley, Chichester, UK
-
Kuba, K.
(1994)
Jpn. J. Physiol.
44,
613-650
[CrossRef][Medline]
[Order article via Infotrieve]
-
McPherson, P. S., Kim, Y. K., Valdivia, H., Knudson, C. M., Takekura, H., Franzini-Armstrong, C., Coronado, R., and Campbell, K. P.
(1991)
Neuron
7,
17-25
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bezprozvanny, I., Watras, J., and Ehrlich, B. E.
(1991)
Nature
351,
751-754
[CrossRef][Medline]
[Order article via Infotrieve]
-
Seymour-Laurent, K. J., and Barish, M. E.
(1995)
J. Neurosci.
15,
2592-2608
[Abstract]
-
Friel, D. D., and Tsien, R. W.
(1992)
J. Physiol. (Lond.)
450,
217-246
[Abstract/Free Full Text]
-
Thayer, S. A., Hirning, L. D., and Miller, R. J.
(1988)
Mol. Pharmacol.
34,
664-673
[Abstract]
-
Brorson, J. R., Bleakman, D., Gibbons, S. J., and Miller, R. J.
(1991)
J. Neurosci.
11,
4024-4043
[Abstract]
-
Sharp, A. H., McPherson, P. S., Dawson, T. M., Aoki, C., Campbell, K. P., and Snyder, S. H.
(1993)
J. Neurosci.
13,
3051-3063
[Abstract]
-
Sah, P., Francis, K., McLachlan, E. M., and Junankar, P.
(1993)
Neuroscience
54,
157-65
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lai, F. A., Dent, M., Wickenden, C., Xu, L., Kumari, G., Misra, M., Lee, H. B., Sar, M., and Meissner, G.
(1992)
Biochem. J.
288,
553-564
-
Sah, P., and McLachlan, E. M.
(1991)
Neuron
7,
257-264
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wang, Y., Rowan, M. J., and Anwyl, R.
(1997)
J. Neurophysiol.
77,
812-825
[Abstract/Free Full Text]
-
Reyes, M., and Stanton, P. K.
(1996)
J. Neurosci.
16,
5951-5960
[Abstract/Free Full Text]
-
Kohda, K., Inoue, T., and Mikoshiba, K.
(1995)
J. Neurophysiol.
74,
2184-2188
[Abstract/Free Full Text]
-
Peng, Y.
(1996)
J. Neurosci.
16,
6703-6712
[Abstract/Free Full Text]
-
Holliday, J., Adams, R. J., Sejnowski, T. J., and Spitzer, N. C.
(1991)
Neuron
7,
787-796
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lee, H. C., Walseth, T. F., Bratt, G. T., Hayes, R. N., and Clapper, D. L.
(1989)
J. Biol. Chem.
264,
1608-1615
[Abstract/Free Full Text]
-
Galione, A., Lee, H. C., and Busa, W. B.
(1991)
Science
253,
1143-1146
[Abstract/Free Full Text]
-
Lee, H. C.
(1993)
J. Biol. Chem.
268,
293-299
[Abstract/Free Full Text]
-
Rakovic, S., Galione, A., Ashamu, G., Potter, B. V. L., and Terrar, D. A.
(1996)
Curr. Biol.
6,
989-996
[CrossRef][Medline]
[Order article via Infotrieve]
-
Thorn, P., Gerasimenko, O., and Petersen, O. H.
(1994)
EMBO J.
13,
2038-2043
[Medline]
[Order article via Infotrieve]
-
Currie, K. P., Swann, K., Galione, A., and Scott, R. H.
(1992)
Mol. Biol. Cell.
3,
1415-1425
[Abstract]
-
Guse, A. H., Berg, I., da Silva, C., Potter, B. V. L., and Mayr, G. W.
(1997)
J. Biol. Chem.
272,
8546-8550
[Abstract/Free Full Text]
-
Hamprecht, B., Glaser, T., Reiser, G., Bayer, E., and Propst, F.
(1985)
Methods Enzymol.
109,
316-326
[Medline]
[Order article via Infotrieve]
-
Docherty, R. J., Robbins, J., and Brown, D. A.
(1991)
in
Cellular Neurobiology: A Practical Approach (Chad, J., and Wheal, H., eds), pp. 75-95, Oxford University Press, Oxford
-
Genazzani, A. A., Empson, R. M., and Galione, A.
(1996)
J. Biol. Chem.
271,
11599-11602
[Abstract/Free Full Text]
-
Hua, S. Y., Nohmi, M., and Kuba, K.
(1993)
J. Physiol. (Lond.)
464,
245-272
[Abstract/Free Full Text]
-
Jin, W., Lee, N. M., Loh, H. H., and Thayer, S. A.
(1993)
Brain Res.
607,
17-22
[CrossRef][Medline]
[Order article via Infotrieve]
-
Usachev, Y., Shmigol, A., Pronchuk, N., Kostyuk, P., and Verkhratsky, A.
(1993)
Neuroscience
57,
845-859
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hua, S. Y., Tokimasa, T., Takasawa, S., Furuya, Y., Nohmi, M., Okamoto, H., and Kuba, K.
(1994)
Neuron
12,
1073-1079
[CrossRef][Medline]
[Order article via Infotrieve]
-
Shmigol, A., Eisner, D., and Verkhratsky, A.
(1994)
J. Physiol. (Lond.)
483,
63P
-
Berridge, M. J.
(1997)
J. Physiol. (Lond.)
499,
291-306
[Free Full Text]
-
Walseth, T. F., Aarhus, R., Zeleznikar, R., Jr., and Lee, H. C.
(1991)
Biochim. Biophys. Acta
1094,
113-20
[Medline]
[Order article via Infotrieve]
-
Shmigol, A., Verkhratsky, A., and Isenberg, G.
(1995)
J. Physiol. (Lond.)
489.3,
627-636
-
Takemura, H., Ohshika, H., Yokosawa, N., Oguma, K., and Thastrup, O.
(1991)
Biochem. Biophys. Res. Commun.
180,
1518-1526
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lo, T. M., and Thayer, S. A.
(1993)
Am. J. Physiol.
264,
C641-C653
[Abstract/Free Full Text]
-
Chueh, S. H., Liu, J. A., and Kao, L. S.
(1990)
J. Neurochem.
55,
1281-1286
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lee, H. C., and Aarhus, R.
(1991)
Cell Regul.
2,
203-209
[Medline]
[Order article via Infotrieve]
-
Docherty, R. J.
(1988)
J. Physiol. (Lond.)
398,
33-47
[Abstract/Free Full Text]
-
Eckert, R., and Trautwein, W.
(1991)
Neurosci. Lett.
119,
123-126
-
Chu, A., Diaz-Munoz, M., Hawkes, M., Brusch, K., and Hamilton, S.
(1990)
Mol. Pharmacol.
37,
735-741
[Abstract]
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Wang, A. G. Teschemacher, J. F. R. Paton, and S. Kasparov
Mechanism of nitric oxide action on inhibitory GABAergic signaling within the nucleus tractus solitarii
FASEB J,
July 1, 2006;
20(9):
1537 - 1539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Gant, M. M. Sama, P. W. Landfield, and O. Thibault
Early and simultaneous emergence of multiple hippocampal biomarkers of aging is mediated by Ca2+-induced Ca2+ release.
J. Neurosci.,
March 29, 2006;
26(13):
3482 - 3490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Soares, M. Thompson, and E. N. Chini
Role of the Second-Messenger Cyclic-Adenosine 5'-Diphosphate-Ribose on Adrenocorticotropin Secretion from Pituitary Cells
Endocrinology,
May 1, 2005;
146(5):
2186 - 2192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Verkhratsky
Physiology and Pathophysiology of the Calcium Store in the Endoplasmic Reticulum of Neurons
Physiol Rev,
January 1, 2005;
85(1):
201 - 279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Morikawa, K. Khodakhah, and J. T. Williams
Two Intracellular Pathways Mediate Metabotropic Glutamate Receptor-Induced Ca2+ Mobilization in Dopamine Neurons
J. Neurosci.,
January 1, 2003;
23(1):
149 - 157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. I. McDonough, Z. Cseresnyes, and M. F. Schneider
Origin Sites of Calcium Release and Calcium Oscillations in Frog Sympathetic Neurons
J. Neurosci.,
December 15, 2000;
20(24):
9059 - 9070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E H Bowden, A. A Selyanko, and J. Robbins
The role of ryanodine receptors in the cyclic ADP ribose modulation of the M-like current in rodent m1 muscarinic receptor-transformed NG108-15 cells
J. Physiol.,
August 15, 1999;
519(1):
23 - 34.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rakovic, Y. Cui, S. Iino, A. Galione, G. A. Ashamu, B. V. L. Potter, and D. A. Terrar
An Antagonist of cADP-ribose Inhibits Arrhythmogenic Oscillations of Intracellular Ca2+ In Heart Cells
J. Biol. Chem.,
June 18, 1999;
274(25):
17820 - 17827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Diaz, M. Setzu, A Zucca, R Isola, A Diana, R Murru, V Sogos, and F Gremo
Subcellular heterogeneity of mitochondrial membrane potential: relationship with organelle distribution and intercellular contacts in normal, hypoxic and apoptotic cells
J. Cell Sci.,
January 4, 1999;
112(7):
1077 - 1084.
[Abstract]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|